Evaluation of in Vitro Antitumor Activity of GD2 CAR-T Cells in Glioblastoma
NCT06764537
·
clinicaltrials.gov ↗
NA
Phase
NOT_YET_RECRUITING
Status
18
Enrollment
OTHER
Sponsor class
Conditions
Glioblastoma
Interventions
PROCEDURE:
Blood collection
Sponsor
Central Hospital, Nancy, France